|
1) Kullak-Ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology. 2004; 126: 322-42
|
|
|
|
2) Dawson PA, Lan T, Rao A. Bile acid transporters. J Lipid Res. 2009; 50: 2340-57
|
|
|
|
|
3) Hagenbuch B, Meier PJ. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na＋/bile acid cotransporter. J Clin Invest. 1994; 93: 1326-31
|
|
|
|
|
|
4) Abe T, Kakyo M, Tokui T, et al. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem. 1999; 274: 17159-63
|
|
|
|
|
|
5) Konig J, Cui Y, Nies AT, et al. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem. 2000; 275: 23161-8
|
|
|
|
|
|
6) Abe T, Unno M, Onogawa T, et al. LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology. 2001; 120: 1689-99
|
|
|
|
|
|
7) Wang W, Seward DJ, Li L, et al. Expression cloning of two genes that together mediate organic solute and steroid transport in the liver of a marine vertebrate. Proc Natl Acad Sci U S A. 2001; 98: 9431-6
|
|
|
|
|
|
8) Seward DJ, Koh AS, Boyer JL, et al. Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta. J Biol Chem. 2003; 278: 27473-82
|
|
|
|
|
|
9) Dawson PA, Hubbert M, Haywood J, et al. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. J Biol Chem. 2005; 280: 6960-8
|
|
|
|
|
|
10) Ballatori N, Christian WV, Lee JY, et al. OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. Hepatology. 2005; 42: 1270-9
|
|
|
|
|
|
11) Strautnieks SS, Bull LN, Knisely AS, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet. 1998; 20: 233-8
|
|
|
|
|
|
12) Strautnieks SS, Byrne JA, Pawlikowska L, et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology. 2008; 134: 1203-14
|
|
|
|
|
|
13) Nozawa T, Sugiura S, Nakajima M, et al. Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity. Drug Metab Dispos. 2004; 32: 291-4
|
|
|
|
|
|
14) Nishizato Y, Ieiri I, Suzuki H, et al. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin Pharmacol Ther. 2003; 73: 554-65
|
|
|
|
|
|
15) Morimoto K, Oishi T, Ueda S, et al. A novel variant allele of OATP-C (SLCO1B1) found in a Japanese patient with pravastatin-induced myopathy. Drug Metab Pharmacokinet. 2004; 19: 453-5
|
|
|
|
|
16) Link E, Parish S, Armitage J, et al. SLCO1B1 variants and statin-induced myopathy―a genomewide study. N Engl J Med. 2008; 359: 789-99
|
|
|
|
|
|
17) Han JY, Lim HS, Shin ES, et al. Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer. Lung Cancer. 2008; 59: 69-75
|
|
|
|
|
|
18) Jung D, Hagenbuch B, Gresh L, et al. Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha. J Biol Chem. 2001; 276: 37206-14
|
|
|
|
|
|
19) Furihata T, Satoh T, Yamamoto N, et al. Hepatocyte nuclear factor 1 alpha is a factor responsible for the interindividual variation of OATP1B1 mRNA levels in adult Japanese livers. Pharm Res. 2007; 24: 2327-32
|
|
|
|
|
|
20) Ohtsuka H, Abe T, Onogawa T, et al. Farnesoid X receptor, hepatocyte nuclear factors 1 alpha and 3 beta are essential for transcriptional activation of the liver-specific organic anion transporter-2 gene. J Gastroenterol. 2006; 41: 369-77
|
|
|
|
|
|
21) Vavricka SR, Jung D, Fried M, et al. The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3beta in hepatocellular carcinoma. J Hepatol. 2004; 40: 212-8
|
|
|
|
|
|
22) Marzolini C, Tirona RG, Gervasini G, et al. A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression. Mol Endocrinol. 2007; 21: 1769-80
|
|
|
|
|
|
23) van Montfoort JE, Stieger B, Meijer DK, et al. Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther. 1999; 290: 153-7
|
|
|
|
|
|
24) Pascolo L, Cupelli F, Anelli PL, et al. Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. Biochem Biophys Res Commun. 1999; 257: 746-52
|
|
|
|
|
|
25) Narita M, Hatano E, Arizono S, et al. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol. 2009; 44: 793-8
|
|
|
|
|
|
26) Muto M, Onogawa T, Suzuki T, et al. Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma. Cancer Science. 2007; 98: 1570-6
|
|
|
|
|
|
27) Oshio H, Abe T, Onogawa T, et al. Peroxisome proliferator-activated receptor alpha activates cyclooxygenase-2 gene transcription through bile acid transport in human colorectal cancer cell lines. J Gastroenterol. 2008; 43: 538-49
|
|
|
|
|
|
28) Fukase K, Ohtsuka H, Onogawa T, et al. Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma. Cancer Sci. 2008; 99: 1785-92
|
|
|
|
|
|
29) Makishima M, Okamoto AY, Repa JJ, et al. Identification of a nuclear receptor for bile acids. Science. 1999; 284: 1362-5
|
|
|
|
|
|
30) Kawamata Y, Fujii R, Hosoya M, et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem. 2003; 278: 9435-40
|
|
|
|
|
|
31) Watanabe M, Houten SM, Mataki C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006; 439: 484-9
|
|
|
|
|
|
32) Altmann SW, Davis HR Jr, Zhu LJ, et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science. 2004; 303: 1201-4
|
|
|
|
|
|
33) Temel RE, Tang W, Ma Y, et al. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest. 2007; 117: 1968-78
|
|
|
|
|
|
34) Valasek MA, Repa JJ, Quan G, et al. Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters. Am J Physiol Gastrointest Liver Physiol. 2008; 295: G813-22
|
|
|
|
|